Cargando…
Inflammation-Mediated Angiogenesis in Ischemic Stroke
Stroke is the leading cause of disability and mortality in the world, but the pathogenesis of ischemic stroke (IS) is not completely clear and treatments are limited. Mounting evidence indicate that neovascularization is a critical defensive reaction to hypoxia that modulates the process of long-ter...
Autores principales: | Zhu, Hua, Zhang, Yonggang, Zhong, Yi, Ye, Yingze, Hu, Xinyao, Gu, Lijuan, Xiong, Xiaoxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096981/ https://www.ncbi.nlm.nih.gov/pubmed/33967696 http://dx.doi.org/10.3389/fncel.2021.652647 |
Ejemplares similares
-
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
por: Zhu, Hua, et al.
Publicado: (2021) -
The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019) -
Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke
por: Xu, Qingxue, et al.
Publicado: (2021) -
Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
por: Zhu, Hua, et al.
Publicado: (2023) -
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)